PUBLIC COMPANY
saveKind Pharmaceuticals
updated 2mo ago
community read0 votes
pipeline
3
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(3)
pipeline depth3 products
1Preclinical1Phase 11Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase3A Study of AND017 to Evaluate Efficacy and Safety in Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Patients With Anemia
- phase3A Study of AND017 to Evaluate Efficacy and Safety in Patients With Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD)
- phase2A Study of Efficacy and Safety of AND017 in Patients With Myelodysplastic Syndrome
- phase1A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- phase2A Study of AND017 in Cancer Related Anemic Patients Receiving Chemotherapy
- phase2A Study of AND017 to Treat Cancer Related Anemia in Patients Not Receiving Chemotherapy
- phase2A Study of Safety and Efficiency of AND017 in Patients With β-thalassemia
- phase2A Study of AND017 to Treat Anemia in Chronic Kidney Disease Patients on Dialysis
🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that